Insulin Side Effects: Optimizing Glycemic Control to Prevent Hypoglycemia and Weight Gain in Diabetic Therapy

Insulin is a fundamental pillar in diabetic therapy, especially for patients with type 1 diabetes and some with type 2 diabetes. However, its use is not without side effects that can complicate disease management. Among the most common are hypoglycemia and weight gain. These effects can significantly impact the patient's quality of life and the efficacy of treatment.
Profundizando en los efectos secundarios de la insulina
Hypoglycemia is one of the most serious risks associated with insulin therapy. This side effect can lead to severe complications, including loss of consciousness and seizures. A recent study highlights the importance of strategies to prevent hypoglycemia in hospitalized patients, suggesting the use of continuous glucose monitoring systems and structured patient education [1].
Weight gain is another common side effect of insulin therapy. This phenomenon can be attributed to improved glycemic control, which leads to greater fat accumulation. Lipohypertrophy, a skin complication related to insulin, can also contribute to weight gain and variability in insulin absorption, affecting glycemic control [2].
Insulin resistance is an additional challenge in diabetes management. The combination of insulin with other pharmacological agents, such as sodium-glucose cotransporter type 2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, has proven effective in improving glycemic control and reducing cardiovascular risk [3].
Conclusiones
Optimizing the use of insulin in diabetic therapy requires a comprehensive approach that considers both the benefits and potential risks. Patient education, continuous glucose monitoring, and the combination of pharmacological therapies are key strategies to minimize side effects such as hypoglycemia and weight gain. By addressing these challenges, we can significantly improve glycemic control and the quality of life for our patients.
Referencias
- [1] Inpatient Hypoglycemia: The Challenge Remains
- [2] Errors in insulin treatment management and risk of lipohypertrophy
- [3] Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians
Created 6/1/2025